Belgium Artificial Intelligence (AI) in Healthcare Market Analysis.pdf

insights10marketing 54 views 69 slides Jul 31, 2024
Slide 1
Slide 1 of 69
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47
Slide 48
48
Slide 49
49
Slide 50
50
Slide 51
51
Slide 52
52
Slide 53
53
Slide 54
54
Slide 55
55
Slide 56
56
Slide 57
57
Slide 58
58
Slide 59
59
Slide 60
60
Slide 61
61
Slide 62
62
Slide 63
63
Slide 64
64
Slide 65
65
Slide 66
66
Slide 67
67
Slide 68
68
Slide 69
69

About This Presentation

This report presents a strategic analysis of the Belgium Artificial Intelligence (AI) in Healthcare Market and a forecast for its development in the medium and long term. It provides a comprehensive overview of the market value, dynamics, segmentation, main players, growth and demand drivers, challe...


Slide Content

Belgium Artificial Intelligence (AI) in
Healthcare Market Analysis
A sample report on

This report presents a strategic analysis of the Belgium Artificial
Intelligence (AI) in Healthcare Market and a forecast for its
development in the medium and long term. It provides a comprehensive
overview of the market value, dynamics, segmentation, main players,
growth and demand drivers, challenges & future outlook, etc. This is
one of the most comprehensive reports about the Belgium Artificial
Intelligence (AI) in Healthcare Market, and offers unmatched value,
accuracy, and expert insights.

3 A Sample Report on Belgium Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
Report Attribute Details
Number of Pages 60-80
Base Year for Estimation 2023
Forecast Period 2024-2030
Report Coverage
Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends,
Competitive Landscape, Key Company Profiles, Government Policies, Regulatory Landscape,
Reimbursement Scenario
Quantitative Units Revenue in USD Million/Billion (Mn/Bn)
Research Approach Secondary Research (60%), Primary Research (40%)
Click on the icon to know the detailed methodology
Report Scope

4 A Sample Report on Belgium Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
CONTENT PG. NO.
1. Market Overview 07-17
1.1. Artificial Intelligence (AI) in Healthcare Overview
1.2. Statistics at a Glance: AI in Healthcare Market in the World
1.3. Healthcare Scenario in the World
1.4. Belgium Overview
1.5. Economic Overview: Belgium
1.6. Statistics at a Glance: AI in Healthcare Market in Belgium
1.7. Healthcare Scenario in Belgium
1.8. Budget of Belgium Government for Public Insurance
1.9. Top Developments in Belgium
2. AI in Healthcare Overview 18-19
2.1. Applications of AI in Healthcare
3. Market Size and Forecasting 20-25
Table of Content

5 A Sample Report on Belgium Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
CONTENT PG. NO.
3.1. Market Size and Forecasts (Excel and Methodology)
3.2. Snapshot of AI in Healthcare Market Segmentation
3.2.1. By Offerings
3.2.2. By Application
3.2.3. By End User
4. Market Dynamics 26-32
4.1. Market Growth Drivers
4.2. Market Restraints
5. Competitive Landscape 33-42
5.1. Major Market Share
5.2. Key Players in Belgium AI in Healthcare Market
5.2.1. ArtiQ
5.2.2. Bingli
Table of Content

6 A Sample Report on Belgium Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
CONTENT PG. NO.
5.2.3. Ovizio
5.2.4. Medicasure
5.2.5. Icometrix
5.2.6. DNAlytics
5.2.7. Awell Health
5.2.8. Nobi
5.2.9. Relu
5.2.10. MintT
6. Reimbursement Scenario 43-48
6.1. Reimbursement Regulation in Belgium
6.2. Reimbursement Process
7. Methodology & Scope 49-69
Table of Content

Belgium Artificial Intelligence (AI) in Healthcare Market Analysis
1. Market Overview

▪Artificial intelligence (AI) is a field of computer science concerned with creating intelligent
machines that can perform tasks (reasoning, learning, problem-solving, and decision-making)
typically requiring human intelligence
▪AI in healthcare refers to the application of various AI technologies to enhance healthcare
professionals' capabilities and improve patient experiences
▪AI plays a crucial role in various aspects of healthcare, including medical diagnosis, drug
discovery, patient experience enhancement, healthcare data management, and robotic surgery
Some key aspects of AI include:
1.1 Artificial Intelligence (AI) in Healthcare Overview
▪Machine Learning: This is a type of AI where computers learn without being explicitly
programmed, usually by analyzing data and identifying patterns
▪Deep Learning: This is a subfield of machine learning that uses artificial neural networks,
inspired by the structure of the human brain
▪Applications of AI: AI is already being used in various industries, including healthcare, finance,
self-driving cars, and recommendation systems

9 A Sample Report on Belgium Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
▪Please be aware that this sample report is
intended to provide you with a brief overview
of the kind of information and analysis that
will be presented in the final report
▪In this section you will get an understanding
of the topic, which includes global statistics
and available details related to the topic
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information related
to the topic or subject matter of interest
Illustrative
1.2 Statistics at a Glance: AI in Healthcare Market in the World
~ $30 Tn
More to the economy will
be contributed by AI by
2030
~ $150 Bn
In healthcare costs could
be saved by AI Application
in the US
19% +
Of the healthcare firms had
adopted AI as of 2021
60%
Of US adults are
uncomfortable with
providers relying in AI

10 A Sample Report on Belgium Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
Belgium Market
~$xx Bn Market
➢Africa: $_ _
➢APAC: $_ _
➢Europe: $_ _
➢LATAM: $_ _
➢Middle East: $_ _
➢North America: $_ _
Regional Analysis
Illustrative
1.3 Healthcare Scenario in the World

11 A Sample Report on Belgium Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
Illustrative
11.7 Mn+
Is the population of
Belgium in 2023
$627 Bn
Is the Gross Domestic
Product in Belgium in
2023
41.3 years
Is the median age in Belgium
in 2023
10.0%
Of Belgium’s GDP is
spent on health in 2023
1.4 Belgium Overview
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In this section you will get an
understanding of the topic, which includes
the demographic data, economic
landscape, and other details related to the
topic
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest

12 A Sample Report on Belgium Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
Population of Belgium, (In Mn) GDP of Belgium, (in $Bn)
Population Split (2023)
By Age GroupBy Gender
▪In this section you will get an understanding of the demographics
of the country/region, which includes the population, GDP,
healthcare expenditure and other details related to the topic
▪In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will
include data, analysis, trends, and other relevant information
related to the topic or subject matter of interest
Illustrative
1.5 Economic Overview: Belgium
11.26
11.32
11.37
11.43
11.49
11.52
11.58
11.69
2016 2017 2018 2019 2020 2021 2022 2023
$476
$502
$543 $535 $526
$600
$583
$627
2016 2017 2018 2019 2020 2021 2022 2023
Male
49%
Female
51%
19%
61%
21%
0-14 Yrs
15-64 Yrs
65+ Yrs

13 A Sample Report on Belgium Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
Illustrative
1.6 Statistics at a Glance: AI in Healthcare Market in Belgium
▪In this section you will get an
understanding of the AI in Healthcare
market, which includes important statistics
and other details related to the topic
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
51+
Companies are present in
AI in Healthcare sector in
Belgium
1.8 Bn
Hours can be saved every
year by the use of AI
Applications
20-25%
Is the adoption rate of AI in
Belgium
8+
Use cases of AI in
Healthcare are identified in
Belgium

14 A Sample Report on Belgium Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
1.7 Healthcare Scenario in Belgium
Public Healthcare
▪Universal Healthcare: The system is primarily funded through
social security contributions, which are a percentage of an
individual's income
▪There are also some contributions from general taxation
Private Healthcare
▪Voluntary: Private healthcare in Belgium is entirely voluntary
▪It's generally used by individuals and expats seeking additional
coverage or services not fully reimbursed by the public system
Insurance
▪Coverage for All: All Belgian residents are required to register
with a sickness fund (health insurance provider)
▪This insurance covers most healthcare costs but private
insurances can also be taken that offer different levels of coverage
Government Programs
▪Health Promotion and Prevention: The government launches
public health campaigns targeting certain issues
▪Campaigns encourage healthier lifestyles and reduce the burden
of non-communicable diseases
Illustrative

15 A Sample Report on Belgium Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
1.8 Budget of Belgium Government for Public Insurance
Proposed Budget By Category
Outlays 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20312022-31
In Billions Of Dollars
Medicare
$769 $709 $766 $841 $840 $947 $1,014 $1,085 $1,227 $1,178 $1,325 $1,412 $10,633
As % Of GDP 3.7% 3.2% 3.3% 3.4% 3.3% 3.6% 3.7% 3.8% 4.1% 3.8% 4.1% 4.2% 3.7%
▪National Health Expenditures (NHE) grew 2.7% to $4.3 Tn in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP)
▪Medicare spending grew 8.4% to $900.8 Bn in 2021, or 21% of total NHE
▪Private health insurance spending grew 5.8% to $1,211.4 Bn in 2021, or 28% of total NHE
▪Out of pocket spending grew 10.4% to $433.2 Bn in 2021, or 10% of total NHE
▪Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 Bn, or 14% of total NHE
▪Hospital expenditures grew 4.4% to $1,323.9 Bn in 2021, slower than the 6.2% growth in 2020
▪Physician and clinical services expenditures grew 5.6% to $864.6 Bn in 2021, slower growth than the 6.6% in 2020
▪Prescription drug spending increased 7.8% to $378.0 Bn in 2021, faster than the 3.7% growth in 2020
▪Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health
spending accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7%
Illustrative

16 A Sample Report on Belgium Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
1.9 Top Developments in Belgium
Company Name Type
Amount /
Duration
Year Key Pointers
Acquisition -
April,
2024
▪Air Liquide has acquired two homecare businesses in Belgium and
the Netherlands that support 10,000 patients living with respiratory
insufficiency, sleep apnea syndrome, or requiring infusion or
nutrition treatments
▪This move was part of the company's strategic expansion efforts in
the healthcare sector
▪It is expected to further solidify Air Liquide's position as a key
player in the healthcare industry, showcasing its dedication to
improving patient care and expanding its market reach
Investment $3 Bn
August,
2023
▪Accenture has created an AI lab in Brussels to develop services
across Europe focused on the health, public sector and NATO
▪It aims to help European governments and healthcare
organizations leverage AI to improve services and outcomes for
citizens
▪Lab will have a core team of 25 people based, with around 90 more
across Europe offering expertise in AI, computer vision, natural
language processing, responsible AI and statistical modeling
Latest Developments in Belgium
Illustrative

17 A Sample Report on Belgium Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
1.9 Top Developments in Belgium (Continued)
Latest Developments in Belgium
Company Name Type
Amount /
Duration
Year Key Pointers
Illustrative

Belgium Artificial Intelligence (AI) in Healthcare Market Analysis
2. AI in Healthcare Overview

19 A Sample Report on Belgium Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
2.1 Applications of AI in Healthcare
Illustrative
▪Analyze large
amounts of medical
data
▪This can help identify
patterns and
correlations for
earlier and more
accurate diagnoses
▪AI models use deep
learning technology
and improve as the
database gets richer
▪Screen millions of
potential drug
compounds to
identify the most
effective and safe
ones
▪This can reduce the
time and cost of
developing new
drugs
▪Develop chatbots for
answering patients'
health questions,
scheduling
appointments,
providing medication
reminders
▪Personalize
treatment plans
▪Provide real-time
feedback on patient
progress.
▪Store, organize, and
analyze vast
amounts of
healthcare data
▪Improve quality of
care by providing
doctors with a more
complete picture of a
patient's health
history
▪Control robotic
surgical systems for
greater precision and
control than
traditional surgery
▪Lead to shorter
recovery times and
fewer complications
for patients
Drug
Discovery
Medical
Diagnosis
Patient
Experience
Robotic
Surgery
Data
Management

Belgium Artificial Intelligence (AI) in Healthcare Market Analysis
3. Market Size and Forecasting

21 A Sample Report on Belgium Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
XX
2023 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Belgium AI in Healthcare Market Forecast, 2023-2030
Click on the icon to know the calculations and assumption
20232024202520262027202820292030
Major Markets Patient
($Mn)
2.74 2.82 2.90 2.94 2.98 3.02 3.07 3.12
Belgium Patient Size
($Bn)
0.51 0.61 0.68 0.69 0.70 0.71 0.72 0.73
% of Patients 18.75%21.70%23.56%23.45%23.42%23.39%23.34%23.45%
Global Market Size ($Bn)3,6203,7803,9504,1284,3144,5084,7114,937
Belgium Market Size
($Bn)
61 74 84 87 91 95 99 106
Illustrative
3.1 Market size and forecasts (Excel and Methodology)
▪In this section you will get an
understanding of the AI in Healthcare
market, which includes important statistics
and other details related to the topic
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest

22 A Sample Report on Belgium Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
▪In this section you will get an understanding of the segmentations which will cover the Belgium AI in Healthcare Market
▪In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
Illustrative
3.2 Snapshot of AI in Healthcare Market Segmentation
By Offering
Hardware
Software
Services
By Application
Robot Assisted Surgery
Clinical Trials
Diagnostics
Others
By End User
Pharma Companies
Hospitals & Clinics
Patients

23 A Sample Report on Belgium Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
Belgium AI in Healthcare Market Share, By Offerings (2023)
Illustrative
3.2.1 Market Segmentation: By Offerings
▪In this section you will get an
understanding of Belgium AI in Healthcare
Market Segmentation by offerings
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
Hardware
Software
Services

24 A Sample Report on Belgium Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
Illustrative
3.2.2 Market Segmentation: By Application
▪In this section you will get an
understanding of Belgium AI in Healthcare
Market Segmentation by application
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
Robot Assisted
Surgery
Clinical Trials
Diagnostics
Others
Belgium AI in Healthcare Market Share, By Application (2023)

25 A Sample Report on Belgium Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
Belgium AI in Healthcare Market Share, By End User (2023)
Illustrative
3.2.3 Market Segmentation: By End User
▪In this section you will get an
understanding of Belgium AI in Healthcare
Market Segmentation by end user
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
Pharma
Companies
Hospitals &
Clinics
Patients

Belgium Artificial Intelligence (AI) in Healthcare Market Analysis
4. Market Dynamics

27 A Sample Report on Belgium Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
4. Snapshot Of Market Growth Drivers And Restraints
Illustrative
4.1.1
Belgium’s
promising
technological
startup
environment
4.1.2
Government
initiatives that
aid in digital
transformation
4.1.3
Lack of
medical staff in
drives demand
for automated
AI solutions
4.1.4
Increasing
disease burden
demands for
effective
solutions
4.2.1
Strict rules on
data
protection and
privacy in the
EU
4.2.2
Lack of trust
in AI and
other digital
tools

28 A Sample Report on Belgium Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
4.1.1 Belgium now boasts a promising technological startup environment, and the
number of unicorns is steadily expanding
Illustrative
▪Please be aware that this sample report is intended to provide you with a
brief overview of the kind of information and analysis that will be
presented in the final report
▪In order to obtain access to all of the information that you are seeking,
you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will include data,
analysis, trends, and other relevant information related to the topic or
subject matter of interest
2010 2023 2030
Growing numbers of unicorns in Belgium

29 A Sample Report on Belgium Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
4.1.2 Belgian government's commitment to implement national digital
transformation by 2025
Illustrative
▪Please be aware that this sample report is intended to provide you
with a brief overview of the kind of information and analysis that will
be presented in the final report
▪In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will include
data, analysis, trends, and other relevant information related to the
topic or subject matter of interest
Government Initiative Description
Initiative 1 --
Initiative 2 --
Initiative 3 --
Initiative 4 --

30 A Sample Report on Belgium Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
▪Please be aware that this sample report is intended to provide you with a
brief overview of the kind of information and analysis that will be
presented in the final report
▪In order to obtain access to all of the information that you are seeking,
you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will include data,
analysis, trends, and other relevant information related to the topic or
subject matter of interest
Illustrative
4.1.3 Local healthcare providers in Belgium are migrating causing lack of medical
staff in the country
Increase in migration of local Medical
Professionals in Belgium
2010 2023 2030

31 A Sample Report on Belgium Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
▪Please be aware that this sample report is intended to provide you with a
brief overview of the kind of information and analysis that will be
presented in the final report
▪In order to obtain access to all of the information that you are seeking,
you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will include data,
analysis, trends, and other relevant information related to the topic or
subject matter of interest
Illustrative
4.1.4 With a growing population and increasing healthcare needs, there is a rising
demand for efficient and effective healthcare solutions
Increase in disease burden in Belgium
2010 2023 2030

32 A Sample Report on Belgium Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
Our analysis will thoroughly investigate the key restraints that may significantly impact business
operations and growth.
Illustrative
4.2 Market Restraints
▪Please be aware that this sample report is intended to
provide you with a brief overview of the kind of information
and analysis that will be presented in the final report
▪In order to obtain access to all of the information that you
are seeking, you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will
include data, analysis, trends, and other relevant information
related to the topic or subject matter of interest
4.2.1 AI uses a huge amount of data and thus complying
to EU’s stringent data protection regulations is
necessary
4.2.2 Certain segment of the population might
harbor hesitancy towards adoption of AI due to lack
of trust in digital tools
▪Please be aware that this sample report is intended to
provide you with a brief overview of the kind of
information and analysis that will be presented in the
final report
▪In order to obtain access to all of the information that
you are seeking, you will need to purchase the final
report
▪Final report will be comprehensive and detailed, and it
will include data, analysis, trends, and other relevant
information related to the topic or subject matter of
interest

Belgium Artificial Intelligence (AI) in Healthcare Market Analysis
5. Competitive Landscape

34 A Sample Report on Belgium Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
Company 1
Company 2
Company 3
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10
Revenue of Major players in the Belgium AI in Healthcare
Market ($ Mn)
Illustrative
5.1 Major Market Share
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In this section you will the understating of
financial overview of the company, which
includes revenue forecasting, segment
revenue and other key details as per
availability
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest

35 A Sample Report on Belgium Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
5.2 Key Players in Belgium AI in Healthcare Market
Illustrative
▪Here is the list of top companies which will
cover in the final report
▪Each company will have slides for
oOverview
oKey details
oOfferings
oName of products
oRecent activities/ Press Coverage
oMergers, Acquisitions and
Collaboration
oFinancials
▪If there are specific companies that you
would like to be included in the report,
please let us know via email
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
ArtiQ1 DNAlytics6
Bingli2 Awell Health7
Ovizio3 Nobi8
Medicasure4 Relu9
Icometrix5 MintT10

5.2.1 ArtiQ
Founded in: 2019
HQ: Leuven, Belgium
Type: Private
Revenue: <$5 Mn (Global)
Website: www.artiq.eu
▪ArtiQ is a local company that leverages AI to enhance respiratory
medicine
▪Their AI-driven software supports the interpretation of pulmonary
function tests (PFTs), providing accurate, timely diagnostics and
follow-up for lung diseases
▪It collaborates with prominent partners and is recognized for its
validated, CE-marked technologies
Offers solutions for:
➢Doctors
➢Clinical Research Organizations
➢Pharma Companies
Products and Platforms
Illustrative
Automated Interpretation
Support for Pulmonary
Function Tests
Automated Interpretation
Support for Spirometry Tests
Instant Artificial Intelligence
Over-reading of Spirometry
Artificial Intelligence -enabled
Risk-Based Monitoring
For Doctors For CROs and Pharma

37 A Sample Report on Belgium Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
Company Name Type
Amount /
Duration
Year Key Pointers
Acquisition -
April,
2024
▪ArtiQ, has recently been acquired by Clario, a prominent
healthcare research and technology company
▪This acquisition aims to revolutionize the respiratory market by
enhancing the quality and efficiency of spirometry data analysis,
ultimately improving patient outcomes and clinical trial results
▪Collaboration between ArtiQ and Clario is set to introduce
innovative solutions that will transform respiratory care globally
Partnership -
February,
2024
▪AstraZeneca and ArtiQ have partnered to advance research on
respiratory conditions and enhance the quality of life for individuals
with lung diseases
▪AstraZeneca believes that the systematic use of ArtiQ.Spiro in
primary care can increase the use of spirometry and help resolve
the underdiagnosis of COPD and other chronic respiratory
diseases
5.2.1 ArtiQ (Continued)
Illustrative
Latest Developments

38 A Sample Report on Belgium Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
20202021202220232024F2025F2026F2027F2028F2029F2030F
5.2.1 ArtiQ (Continued)
Revenues ($Bn), 2020-2030
Breakdown of Net Revenue by Segment, 2023
1 2 3 4
Illustrative
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In this section you will the understating of
financial overview of the company, which
includes revenue forecasting, segment
revenue and other key details as per
availability
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest

5.2.2 Bingli
Founded in:
HQ:
Type:
Revenue:
Website:
Solutions offered by Company
Drugs Indications
Drugs for OTC Recent Activity / Press Coverage

40 A Sample Report on Belgium Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
5.2.2 Bingli (Continued)
Major Distribution Partners Major Vendor Partners
Partnerships Ecosystem

41 A Sample Report on Belgium Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
5.2.2 Bingli (Continued)
Company Name Type
Amount /
Duration
Year Key Pointers
Latest Developments

42 A Sample Report on Belgium Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
xx
xx
xx
20202021202220232024F2025F2026F2027F2028F2029F2030F
5.2.2 Bingli (Continued)
Revenues ($Bn), 2020-2030
Breakdown of Net Revenue by Segment, 2022
1 2 3 4
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In this section you will the understating of
financial overview of the company, which
includes revenue forecasting, segment
revenue and other key details as per
availability
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest

Belgium Artificial Intelligence (AI) in Healthcare Market Analysis
6. Reimbursement Scenario

44 A Sample Report on Belgium Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
6.1 Reimbursement Regulation in Belgium
Belgium, as part of the European Union (EU), adheres to healthcare and pharmaceutical regulations primarily governed by EU regulations and
directives
▪European Medicines Agency (EMA) plays a central role in coordinating the evaluation and supervision of medicinal products throughout
the EU, ensuring uniform standards and safety across member states: EMA is responsible for the scientific evaluation, supervision, and
safety monitoring of medicines in the EU, fostering cooperation among national regulatory authorities to harmonize regulatory processes
▪However, each EU member state, including Belgium, also has its national regulatory authority responsible for implementing and enforcing EU
pharmaceutical regulations at the national level
▪In Belgium, the main regulatory authority responsible for medicines and health products is the Federal Agency for Medicines and Health
Products (FAMHP): FAMHP, working closely with the EMA oversees the quality, safety, and efficacy of medicines and health products on the
Belgian market
▪In addition to the FAMHP, the Belgian Data Protection Authority (DPA) plays a crucial role in enforcing compliance with data protection
laws
▪Additionally, Belgium has recently established the Health Data Authority (HAD) to oversee the sharing and use of healthcare data: HDA
aims to facilitate the responsible use of health information to improve public health outcomes and advance medical research
Regulatory Framework In Belgium
Illustrative

45 A Sample Report on Belgium Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
6.1 Reimbursement Regulation in Belgium
The core healthcare regulatory schemes related to digital health are:
▪the Act on the Performance of the Healthcare Professions of 10 May 2015;
▪the Act on Hospitals and Other Care Facilities of 10 July 2008;
▪the Health Care Quality of Practice Act of 22 April 2019;
▪the Patients’ Rights Act of 22 August 2002;
▪the Law on Medicines of 25 March 1964;
▪the EU Regulation 2017/745 on Medical Devices (MDR); Medical Devices Act of 22 December 2020; EU Regulation 2017/746 on In Vitro
Diagnostic Medical Devices (IVDMDR) of 5 April 2017; In Vitro Diagnostic Medical Devices Act of 15 June 2022;
▪the Law on Experiments with Humans of 7 May 2004; EU Regulation 536/2014 on clinical trials on medicinal products for human use of 16
April 2014; and
▪a number of legislative initiatives and already adopted instruments in light of the EU’s digital strategy, such as the Digital Services Act (EU
Regulation 2022/2065), the EU proposal for an AI Act, and general data strategy, such as the Data Governance Act (DGA) (EU Regulation
2022/868) and the recently adopted Data Act (EU Regulation 2023/2854).
Regulatory Framework for Digital Health In Belgium
Illustrative

46 A Sample Report on Belgium Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
6.1 Reimbursement Regulation in Belgium (Continued)
Coverage Penetration (% Total Population) Source of Funding
Spend on Healthcare (%of Current Health Expenditure)
Reimbursement Market Trends
Public healthcare coverage is provided by the government and includes
programs like Medicare and Medicaid
Medicare is a federal program that provides healthcare coverage to individuals
who are 65 years of age or older, as well as certain younger people with
disabilities
▪Shift towards value-based care has been a significant trend in Belgium healthcare system, with payers and providers increasingly focused on improving patient
outcomes and reducing costs
▪This has led to the development of alternative payment models such as accountable care organizations (ACOs) and bundled payment arrangements, which
incentivize providers to deliver high-quality, cost-effective care
38.9% 37.1% 35.6% 32.5% 31.5%
44.0%
46.0% 47.7%
51.0% 51.8%
2017 2018 2019 2020 2021 2022 2023
Government Expenditure
Private Health Insurance
Out of Pocket
Other
NA NA
100% 100% 100% 100% 100%
xx
xx xx
xx xx
2019 2020 2021 2022 2023
Public Healthcare
Coverage
Private Coverage
6.3% 4.08% 5.1% 3.8% 2.2% 2.4% 3.6% GDP Growth (yoy)
14.7% 11.3% 15.5% 7.5% 4.2% NA NA HC Spend Growth (yoy)
Illustrative

47 A Sample Report on Belgium Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
6.2 Reimbursement Process
The reimbursement process in Belgium healthcare system can be complex and can vary depending on the type of healthcare service,
the healthcare provider, and the insurance coverage. Here are the general steps involved in the reimbursement process:
▪Service or Treatment Provided: The healthcare provider performs a service or treatment for the patient
▪Billing: The healthcare provider submits a claim to the insurance company or other payer, requesting reimbursement for the
service provided
▪Adjudication: The insurance company or other payer reviews the claim to determine whether it meets the criteria for
reimbursement. This can involve verifying the patient's eligibility, reviewing the treatment provided, and checking for any potential
errors or fraud
▪Payment: If the claim is approved, the insurance company or other payer reimburses the healthcare provider for the service
provided, based on the negotiated payment rates or fee schedule
▪Patient Responsibility: Depending on the patient's insurance coverage, they may be responsible for paying a portion of the cost
of the service, such as deductibles, co-payments, or co-insurance
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the
topic or subject matter of interest
Illustrative

48 A Sample Report on Belgium Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
6.3 Reimbursement Process (Continued)
The reimbursement process in Belgium healthcare system can be complex
and can vary depending on the type of healthcare service, the healthcare
provider, and the insurance coverage. Here are the general steps involved
in the reimbursement process:
▪Service or Treatment Provided: The healthcare provider performs a
service or treatment for the patient
▪Billing: The healthcare provider submits a claim to the insurance
company or other payer, requesting reimbursement for the service
provided
▪Adjudication: The insurance company or other payer reviews the claim
to determine whether it meets the criteria for reimbursement. This can
involve verifying the patient's eligibility, reviewing the treatment
provided, and checking for any potential errors or fraud
▪Payment: If the claim is approved, the insurance company or other
payer reimburses the healthcare provider for the service provided,
based on the negotiated payment rates or fee schedule
Illustrative
MoH
Private Payers Public Payers
Health Technology Assessment
PaymentCoverageCoding
Coding depends on availability code while coverage and
payment process decisions are made through an HTA.
Market Authorization
1 32

A division of

Life-sciences Market Research
Reports you can trust
www.insights10.com
We maintain an extensive database comprising
over 30,000 syndicated market research reports
within the pharmaceuticals and healthcare sector,
offering a global, regional, and country-level
perspective. Our services also include the provision
of customized research reports, meticulously
tailored to align with your specific requirements.

At Insights10, our extensive report
library spans a diverse range of
categories within the field of life
sciences.
Market Research
Reports across various
categories in healthcare
www.insights10.com
Digital
Health
Medical
Devices
Healthcare
Services
Rare
Diseases
Clinical
Trials
OTC &
Nutraceuticals
Pharma
(Diseases
& Drugs)

Click on the country to see the reports
available
Global Coverage
North America
•US
•Canada
Latin America
•Brazil
•Argentina
•Mexico
•Ecuador
•Venezuela
•Senegal
Europe
•UK
•Germany
•France
•Italy
•Spain
•Russia
•Netherlands
•Sweden
•Romania
•Switzerland
• Poland
• Austria
• Ireland
• Norway
• Denmark
• Belgium
• Portugal
• Ukraine
• Bulgaria
• Finland
APAC
• India
• China
• South Korea
• Japan
• Australia
• Indonesia
• Hong Kong
• New Zealand
• Philippines
• Singapore
• Malaysia
• Thailand
• Belgium
Middle East
•UAE
•Belgium
•Turkey
•Lebanon
•Kuwait
•Qatar
Africa
•Egypt
•Kenya
•South Africa
•Algeria
•Nigeria
•Libya
•Tanzania
•Morocco

What do our reports cover?
Market Overview
Growth Drivers & Growth Restraints
Epidemiology & Disease type
Market Size & Forecast
Competitive Landscape
Policy & Regulatory Landscape
Reimbursement Scenario
Recent Developments
Market Segmentation Factors Driving Future Growth
1
2
3
4
5
6
7
8
9
10

01 0302 04 05
Define
precise
research
questions
Validate data
through primary
research
interviews
Gather data
through
secondary
research
Forecast
market size
and segment
analysis
Extract key
insights from
the research
findings
06
Compile &
present a
comprehensive
analytical report
Our Research Process

Bottom Up Approach
Analyze product or treatment pricing
and reimbursement strategies
Evaluate consumer or patient
demographics and numbers
Predict future market
growth or decline based
on key market trends &
dynamics
Find
final
market size
Top Down Approach
Examine the total healthcare expenditure in
the targeted disease or service domain.
Assess the proportion of spending
allocated to the specific product or
treatment category.
Predict future market
growth or decline
based on key market
trends & dynamics
Find
final
market
size
Data Triangulation & Data Validation

2023
2024-
2030
Report Attribute
Quantitative Units
Pricing and Purchase
Revenue in USD Million/Billion (Mn/Bn)
Our pricing and purchase options are adaptable to
suit the specific scope of work.
Details Time Frame
Base
Year for
estimation
Forecast
Period
Report Scope
Delivery Timeline
Typically, the delivery of the final report falls within a
timeframe of 5 to 7 business days, but the exact
duration may vary depending on the project's scope.
Customization
We are pleased to offer you the option of
customizing the report to align with your specific
research requirements at no extra charge, provided
it falls within the defined scope of the project.

We have access to a multitude of highly
dependable data sources, supported by
years of experience that guide us in
discerning which sources are most reliable
and current for the specific information
needed.
Access to credible
data sources for
secondary research
www.insights10.com
Statistical
Databases
Annual
Reports
Trade
Publications
Online
Databases
Published
Research
Reports
White-
papers
Press
Releases

Reliable
Expert Verified
Realistic
Comprehensive
Easy to read
Our reports present data, which is
The report is prepared using a proven methodology and insightful
research
The report is prepared by a team of highly qualified & experienced
research analysts & vetted by our local associates
The report allows you to confidently make smarter business and
strategic decisions based on realistic findings
Covers everything you would need to know about the market
including market size, competitive analysis & much more
You do not have to be a market expert to understand what really is
happening on the market and how it works

Yearly Access
(Subscription)
Regulatory
Compliance
Competitive
Intelligence
Conference
Coverage
Full-Time
Engagement
Database Service
& KOL Mapping
Primary Research &
Interviews
Customized Market
Research Reports
Syndicated Market
Research Reports
Our Services

“The business decision-making process is no longer as
straightforward as it used to be. It requires insights
generated at the right time, based on reliable data
interpreted in a nuanced manner for each market. We at
Insights10 are building the future of market research and
are committed to providing our clients with the right
intelligence and insights to make business decisions
quickly and efficiently.
Insights10 is a unique platform that combines deep
domain expertise, nuanced data at a country and
functional area level, and years of experience working with
some of the best organizations in the world, generating
insights that provides substantial competitive advantage.”
Dr. Purav Gandhi, Founder & CEO
Click to watch Our Introductory Video here
CEO Speaks

Purav is a physician and an
entrepreneur with 12+ years of
experience in Healthcare & Life
Sciences industry spanning across
strategy, market access, health
informatics and RWE, digital health,
analytics and data science. Purav
studied medicine from Gujarat
University and also completed his MBA
from IIM-Kozhikode. Purav started his
career with Deloitte working on strategy
consulting engagements and also co-
founded ConvergeHealth by Deloitte.
Anish has 15+ years of
experience in management
consulting in the Life Sciences
sector, and has worked with
diverse multinational firms in
the US, India, Middle East and
APAC regions. His primary area
of interest is Customer and
Market Strategy, Market
Access, and Digital Health with
special focus on emerging
markets like Africa, Middle East
and APAC.
Dr. Purav Gandhi
Founder & CEO
Anish Swaminathan
Director
Mukesh is an engineering graduate with
an MBA in Marketing. He is a seasoned
healthcare market research &
marketing professional with a
progressive experience of over 20
years in Life Sciences, Healthcare
services, Pharma and Medical Device
sectors. With an in-depth understanding
of primary research, he has conducted
hundreds of interviews of various
stakeholders in pharma & healthcare &
completed several research projects
across life sciences industry.
Ritu has over 6 years of experience in
strategy building, market assessments,
market sizing, and RWE for global MNC
healthcare & biopharma clients across
diff. markets (America, Belgium, Africa,
APAC and Middle East). Her areas of
expertise include: Indentifying emerging
trends in life sciences industry,
Competitor landscape assessment,
Disease opportunity assessments etc.
She is a pro in secondary and primary
research with a deep domain expertise
in healthcare sector.
Mukesh Nayak
Head – Marketing & Research
Ritu Baliya
Engagement Manager
Leadership Team

@Our Team

@Work

Beyond Work

… and many more
Pi-SM
GmbH
Our Clients

I've had the pleasure of availing Insights10’s services several times, and I've always
been impressed by their expertise, professionalism, and dedication to providing us with
the highest quality data and insights. Whether one is looking to launch a new product,
expand into a new market, or better understand one's target customers, Insights10
insures achieving the goals.
Their team of experts has a deep understanding of the healthcare industry, and they use
their knowledge to develop customized research solutions that meet the specific needs
of each client. I highly recommend Insights10 to anyone looking for a reliable and
experienced partner in healthcare market research. They're a valuable asset to any
company that wants to succeed in this dynamic sector.
Sid Panigrahy
Founder-CEO, MediGlobo Inc.,
(Healthcare - Group Company of Omi Holdings, Inc) Tampa, Florida (USA)
What our clients say

Dear Insights10 Team, I wanted to thank you all for the great work you conducted
producing the Kenya Medical and Diagnostic Laboratory Service Market Analysis. The
quality of the report was excellent, and you managed to complete it in record time. I was
also impressed by your quick turnaround on the topics discussed as a follow up after the
report's first version; you managed to gather the information required, plus a very good
analysis.
I will definitely consider working with you again if the opportunity arises, and will not
hesitate in recommending you to colleagues working in the field Thank you again for
your professionalism and team work. It was a pleasure working with you.
Lelio Marmora
CEO, The Management Lab, Geneva
Ex. Executive Director, UNITAID
What our clients say

Michael Blumberg Youssef Mallat
Wissem Menad
Dr. Robert Ryan
Co Founder GFAU Pty Ltd., Belgium
Co Founder – Embi, Optimum Oral care, Belgium
Opusline, A part of Accenture, Paris
Senior Manager Segment Marketing
Performance Health,London, UK
Chief Executive Officer, Innova Therapeutics, Inc., USA
We engaged INSIGHTS10 to assist us with our research requirements
for the Oral Care Market sector in Belgium. We been very impressed
with the depth and quality of data and equally with the personal
service we experience from the management team on our account.
They understand our business, our challenges and our goals. There is
a real sense of partnership as we continue to work together.
The info you delivered on the Belgiuman
Patient Support Market with a deep dive into
countries like Spain, Germany, Italy, France,
UK and Belgium, was very useful.
Insights10 has been a great resource for
getting a detailed report on the UK
Physiotherapy Market. Usually I had multiple
sources for getting global reports, but now I
can get in-depth country reports from
Insights10 which has been a game changer.
We were looking for very specific information regarding Abu Dhabi
Oncology Drugs Market. The insights provided by Insights10 is
fantastic and they just took less than three days to deliver the report.
What our clients say

Thank You
www.insights10.com
Email: [email protected]
India: (+91) 931 639 7935
We would be happy to help.
Do you have
any questions?